Stool test may spot hidden bleeding in heart patients on blood thinners

NCT ID NCT07327853

Not yet recruiting Diagnosis Sponsor: Jordan Collaborating Cardiology Group Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will test 200 adults who are about to start blood thinners for heart conditions. Each person will provide a stool sample before starting the medication and again three months later. The goal is to see if the fecal immunochemical test (FIT) can detect hidden gastrointestinal bleeding early, which could help doctors take action sooner.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Fecal Immunochemical Test (FIT)
What this could lead to: If successful, this could show that FIT is a useful tool for early detection of gastrointestinal bleeding in patients on blood thinners.
What could go wrong: This is an early observational study with only 200 participants, so results may not apply to everyone. The test may not catch all bleeding cases.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANTIPLATELET AGENTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiovascular disorder Gastrointestinal Hemorrhage

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANTIPLATELET AGENTS GASTROINTESTINAL BLEEDING ORAL ANTICOAGULANT THERAPY

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Istishari hospital

Amman, 11184, Jordan

More trials for these conditions

Other studies related to the condition(s) this trial covers.